FDA Inspection
Southern Sales & Services Inc.Southern Sales & Services Inc. – FDA Inspection, Mar 29, 2019
Record Details
This FDA Inspection record concerns Southern Sales & Services Inc., with an inspection on March 29, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 048df8f2-4da6-424e-a768-dd885f6b8be5
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1084282
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 211.165(d)Acceptance criteria for sampling & testing
- 21 CFR 211.142(a)Quarantine - actual practice
- 21 CFR 211.198(a)Procedures to be written and followed
- 21 CFR 211.22(a)Lack of quality control unit
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Southern Sales & Services Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| August 7, 2025 | VAI | Florida District Office | Drug Quality Assurance |
Other documents for Southern Sales & Services Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.